Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nu Skin Enterprises reports $2.23B revenue for 2022, focuses on innovation and social commerce

Nu Skin Enterprises navigated challenges in 2022, focusing on innovation and social commerce to drive revenue growth. The company aims to overcome challenges in 2023 and achieve Nu Vision 2025 goals through strategic initiatives. Nu Skin's emphasis on enhancing the iO experience and optimizing expenses positions it for sustainable value to investors.

Nu Skin Enterprises meets Q1 expectations, eyes growth in Asia

Nu Skin's Q1 performance in line with expectations, with notable success in key markets like South Korea and Mainland China.
Challenges persist in certain regions due to macroeconomic factors, necessitating strategic adjustments for sustained growth.
Opportunities lie in expanding TRMe program, leveraging digital initiatives, and driving operational improvements for long-term value creation.

Nu Skin reports robust Q2 earnings, eyes growth through acquisitions

Nu Skin Enterprises delivered strong Q2 results driven by Mainland China growth, with revenue of $500.3 million and EPS of $0.54. The company faces challenges in other markets due to macro-related pressures.
Strategic acquisitions of BeautyBio and LifeDNA aim to enhance Nu Skin's core business through personalization and technology. The company's focus on innovation and market trends presents growth opportunities.
With a clear strategic direction, Nu Skin is poised to navigate challenges, capitalize on opportunities, and drive continued growth in the beauty and wellness industry.

Nu Skin reports Q3 revenue of $499M, adjusts 2023 guidance

Nu Skin adjusts 2023 guidance, expecting revenue of $1.92B to $1.96B and EPS of negative $0.10 to $0.05. The company is streamlining expenses and maximizing cash flow.

Nu Skin surpasses Q4 revenue targets, eyes growth opportunities

Nu Skin Enterprises delivered strong Q4 results, exceeding revenue guidance and showcasing a focus on innovation and strategic growth initiatives.
Despite challenges in certain regions, the company demonstrated resilience and stability in key markets, laying the groundwork for future expansion and market penetration.
By rebalancing dividends for growth investments and prioritizing reinvestment in the business, Nu Skin is poised to capitalize on opportunities for market diversification and sustainable growth.
With a clear roadmap for 2024, including product launches, market entries, and capital reallocation strategies, Nu Skin is well-positioned to drive performance and enhance shareholder value.

Nu Skin Enterprises reports robust Q1 earnings, eyes global expansion

Nu Skin Enterprises showcased resilience in revenue and earnings, driven by strong performance in core and new business segments.
While facing challenges from macroeconomic factors, the company is strategically focused on innovation, cost efficiency, and market expansion.
Opportunities lie in product diversification, market entries, and sustainability efforts, positioning Nu Skin for future growth and market leadership.

Nu Skin surpasses Q2 revenue targets, eyes growth amid challenges

Nu Skin Enterprises delivered strong Q2 performance, exceeding revenue guidance and showcasing financial discipline. Despite challenges in China and FX pressures, the company remains focused on innovation and growth. Strategic investments in new products, markets, and brand awareness position Nu Skin for future success. Revised guidance reflects adaptability to market conditions and commitment to long-term vision.

Nu Skin Enterprises meets Q3 guidance, eyes India expansion

Nu Skin's Q3 performance reflects a balanced approach to addressing challenges and leveraging strengths.
Strategic initiatives to drive growth, optimize operations, and expand into new markets are key focus areas.
Despite market pressures, Nu Skin's focus on innovation and efficiency bodes well for future growth.
Overall, Nu Skin's financials and strategic direction indicate a resilient and forward-thinking company.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin Enterprises Inc (NYSE: NUS) expects third-quarter revenue of $637 million -$642 million (consensus $710.11 million), down from the previous guidance of $700 million - $730 million. Nu Skin noted unanticipated government restrictions had impacted its ability to sell and distribute products, with the largest impact in Mainland China and Southeast Asia.

Nu Skin Cuts Q3 Revenue Outlook As Delta Variant Disrupts Sales

Shares of Nu Skin Enterprises Inc. NUS, +2.50% dropped 3.6% toward a 15-month low in premarket trading Monday, after the personal care products company warned of a revenue miss, saying the delta variant has led to unexpected COVID-related disruptions. The company said it estimates third-quarter revenue of $637 million to $642 million, below the FactSet consensus of $710 million.

Nu Skin stock drops toward 15-month low after warning of revenue miss

PROVO, Utah, Oct. 4, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced estimated third quarter revenue between $637 and $642 million. "Our third quarter revenue was softer than anticipated as the delta variant created unexpected disruptions in many of our markets," said Ryan Napierski, president and CEO of Nu Skin.

Nu Skin Enterprises Provides Estimated Third Quarter Revenue

NUS is exposed to an attractive market and is now resorting to social commerce with greater fervor to attract more clients.

Nu Skin: Key Themes

Yamana Gold

Meritor

V.F.

Vertex Pharmaceuticals

These stocks are disconnected from their earnings outlook as the analysts remain bullish but the Street is bearish.

5 Top Ranked Stocks on Sale Right Now

Bristol-Myers

Ironwood Pharma

The Baby Boomers are getting older, which means investors should consider adding undervalued healthcare stocks to their portfolio. The post 3 Cheap Healthcare Stocks to Buy Right Now appeared first on InvestorPlace.

3 Cheap Healthcare Stocks to Buy Right Now

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Nu Skin Enterprises (NUS) is a Top-Ranked Value Stock: Should You Buy?

Foot Locker

G-III Apparel Group

Hibbett Sports

MetLife

Piper Sandler Cos

Standard Motor Products

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, GIII, NUS, MET, PIPR, HIBB, and SMP are promising picks.

7 Low Price-to-Sales Stocks to Buy in the Current Market

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Why Is Nu Skin (NUS) Down 8.2% Since Last Earnings Report?

KB Home

ArcelorMittal

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, MT, NUS, MET, PIPR, KBH, and SMP are promising picks.

Scoop Up These 7 Low Price-to-Sales Stocks Reflecting Strength

Bassett Furniture

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like HIBB, BSET, NUS, MET, MT, KBH, and SMP are promising picks.

7 Low Price-to-Sales Stocks to Replenish Your Portfolio

Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.

Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y

Nu Skin Enterprises, Inc.'s (NUS) CEO Ritch Wood on Q2 2021 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 8.49% and 0.21%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Beat Estimates

PROVO, Utah, Aug. 4, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter 2021 revenue of $704.1 million and earnings per share (EPS) of $1.15 driven by an increase in operating margin of 260 basis points. Executive Summary Q2 2021 vs.

Nu Skin Enterprises Reports 42 Percent EPS Growth And 15 Percent Revenue Growth In The Second Quarter

Nu Skin's (NUS) second-quarter 2021 performance is likely to reflect gains from the company's efforts to strengthen sales leader and expand customer. Also, online strength has been a driver.

Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Skin Enterprises (NUS) Earnings Expected to Grow: Should You Buy?

Nu Skin Enterprises (NUS) has been struggling lately, but the selling pressure may be coming to an end soon

Nu Skin (NUS) Sees Hammer Chart Pattern: Time to Buy?

Nu Skin Enterprises Inc (NYSE: NUS) subsidiary Grōv Technologies has signed an agreement with California-based Superior Farms for 10 Olympus Tower Farms to produce fresh year-round feed for Superior's upcoming Sheep Discovery Center in Central Utah. Under the agreement, the ten farms will produce 60,000 pounds of Grōv's High-Density Nutrient Super feed wheatgrass a day using less than 5% of the water, without pesticides or herbicides.

Nu Skin Subsidiary Signs Agreement With Superior Farms

VINEYARD, Utah, July 12, 2021 /PRNewswire/ -- Agtech and indoor farming company, Grōv Technologies, today announced a definitive agreement with California-based Superior Farms for the purchase of 10 Olympus Tower Farms that will produce fresh year-round feed for Superior's upcoming Sheep Discovery Center™ in Central Utah. Grōv is part of Superior Farms' efforts to dramatically improve the sustainability and growth of U.S. lamb production.

Grōv Technologies Signs Definitive Agreement with Superior Farms to Bring Sustainability to Ground-breaking U.S. Lamb Production

Quanex Building Products

Sonoco Products

Toronto-Dominion Bank

Weingarten Realty

The crux of safe investment lies in choosing a company that is not overburdened with debt as a debt-free stock is almost impossible to find. You may buy NUS, SON, NX, WRI and TD.

Buy These 5 Low Leverage Stocks to Keep Debt Risks Away

PROVO, Utah, July 7, 2021 /PRNewswire/ -- Nu Skin (NYSE: NUS) is hosting its annual Force for Good Day as part of its commitment to humanitarian efforts both locally and globally. It is a day set aside for Nu Skin brand affiliates, employees and their families to participate in local service projects focused on benefiting the lives of thousands of at-risk children around the globe.

Nu Skin Hosts Annual Force for Good Day to Give Back to Local Communities

PROVO, Utah, July 6, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second-quarter results after the market closes on Wednesday, Aug. 4. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m.

Nu Skin Enterprises To Announce Second-Quarter Results

Baker Hughes Co

LyondellBasell Industries

TravelCenters of America

New Strong Buy Stocks for July 2nd

Nu Skin (NUS) is focused on empowering sales leaders and customers through product launches and engaging technology platforms, among other initiatives.

News for Nu Skin Enterprises Stock (NUS)